Cargando…
Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immuno...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541816/ https://www.ncbi.nlm.nih.gov/pubmed/28808657 http://dx.doi.org/10.1155/2017/4389525 |
_version_ | 1783254883745398784 |
---|---|
author | Sanina, Nina Chopenko, Natalia Mazeika, Andrey Kostetsky, Eduard |
author_facet | Sanina, Nina Chopenko, Natalia Mazeika, Andrey Kostetsky, Eduard |
author_sort | Sanina, Nina |
collection | PubMed |
description | New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immunostimulating complexes (TI-complexes) are a new type of nanoparticulate antigen delivery systems with adjuvant activity. TI-complexes consist of cholesterol and compounds isolated from marine hydrobionts: cucumarioside A2-2 (CDA) from Cucumaria japonica and monogalactosyldiacylglycerol (MGDG) from marine algae or seagrass. These components were selected due to immunomodulatory and other biological activities. Glycolipid MGDG from marine macrophytes comprises a high level of polyunsaturated fatty acids (PUFAs), which demonstrate immunomodulatory properties. CDA is a well-characterized individual compound capable of forming stable complex with cholesterol. Such complexes do not possess hemolytic activity. Ultralow doses of cucumariosides stimulate cell as well as humoral immunity. Therefore, TI-complexes comprising biologically active components turned out to be more effective than the strongest adjuvants: immunostimulating complexes (ISCOMs) and complete Freund's adjuvant. In the present review, we discuss results published in series of our articles on elaboration, qualitative and quantitative composition, ultrastructure, and immunostimulating activity of TI-complexes. The review allows immersion in the history of creating TI-complexes. |
format | Online Article Text |
id | pubmed-5541816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-55418162017-08-14 Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems Sanina, Nina Chopenko, Natalia Mazeika, Andrey Kostetsky, Eduard Biomed Res Int Review Article New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immunostimulating complexes (TI-complexes) are a new type of nanoparticulate antigen delivery systems with adjuvant activity. TI-complexes consist of cholesterol and compounds isolated from marine hydrobionts: cucumarioside A2-2 (CDA) from Cucumaria japonica and monogalactosyldiacylglycerol (MGDG) from marine algae or seagrass. These components were selected due to immunomodulatory and other biological activities. Glycolipid MGDG from marine macrophytes comprises a high level of polyunsaturated fatty acids (PUFAs), which demonstrate immunomodulatory properties. CDA is a well-characterized individual compound capable of forming stable complex with cholesterol. Such complexes do not possess hemolytic activity. Ultralow doses of cucumariosides stimulate cell as well as humoral immunity. Therefore, TI-complexes comprising biologically active components turned out to be more effective than the strongest adjuvants: immunostimulating complexes (ISCOMs) and complete Freund's adjuvant. In the present review, we discuss results published in series of our articles on elaboration, qualitative and quantitative composition, ultrastructure, and immunostimulating activity of TI-complexes. The review allows immersion in the history of creating TI-complexes. Hindawi 2017 2017-07-20 /pmc/articles/PMC5541816/ /pubmed/28808657 http://dx.doi.org/10.1155/2017/4389525 Text en Copyright © 2017 Nina Sanina et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Sanina, Nina Chopenko, Natalia Mazeika, Andrey Kostetsky, Eduard Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems |
title | Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems |
title_full | Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems |
title_fullStr | Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems |
title_full_unstemmed | Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems |
title_short | Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems |
title_sort | nanoparticulate tubular immunostimulating complexes: novel formulation of effective adjuvants and antigen delivery systems |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541816/ https://www.ncbi.nlm.nih.gov/pubmed/28808657 http://dx.doi.org/10.1155/2017/4389525 |
work_keys_str_mv | AT saninanina nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems AT chopenkonatalia nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems AT mazeikaandrey nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems AT kostetskyeduard nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems |